MCD
60
-2
AN
55
-3
XOM
50
-6
DUK
40
-5
OKE
64
-7
PNW
59
6
CNX
61
-8
VRSK
35
-7
RL
69
-4
EQR
62
-5
SCHW
55
-3
AKAM
45
-3
FITB
53
-6
HSIC
44
-10
PDCO
44
-5
WBA
22
-5
VTR
75
-3
XRX
45
-3
KSS
28
-4
SIG
70
-8
MCD
60
-2
AN
55
-3
XOM
50
-6
DUK
40
-5
OKE
64
-7
PNW
59
6
CNX
61
-8
VRSK
35
-7
RL
69
-4
EQR
62
-5
SCHW
55
-3
AKAM
45
-3
FITB
53
-6
HSIC
44
-10
PDCO
44
-5
WBA
22
-5
VTR
75
-3
XRX
45
-3
KSS
28
-4
SIG
70
-8
Financhill
Back

Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings

Election Shock on August 19th?

Click here now to see the evidence I've gathered.
Sell
49

BMRN
Biomarin Pharmaceutical

Last Price:
83.34
Seasonality Move:
6.56%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Biomarin Pharmaceutical Price Quote

$83.34
+2.58 (+3.19%)
(Updated: May 1, 2024 at 6:55 PM ET)

Biomarin Pharmaceutical Key Stats

Sell
49
Biomarin Pharmaceutical (BMRN) is a Sell
Day range:
$80.52 - $81.79
52-week range:
$76.02 - $99.56
Dividend yield:
0%
P/E ratio:
92.83
P/S ratio:
6.32
P/B ratio:
3.02%
Volume:
1.7M
Avg. volume:
1.6M
1-year change:
-15.91%
Market cap:
$15.3B
Revenue:
$2.4B
EPS:
$1.07

How Much Does Biomarin Pharmaceutical Make?

Is Biomarin Pharmaceutical Growing As A Company?

Biomarin Pharmaceutical Stock Price Performance

What Is Biomarin Pharmaceutical 52-Week High & Low?

Biomarin Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Biomarin Pharmaceutical?

Is Biomarin Pharmaceutical Cash Flow Positive?

  • What Is BMRN Cash Flow From Operations?
    Cash flow from operations (TTM) is $280.2M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$20.8M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$95.5M

Biomarin Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    BMRN return on invested capital is 3.45%
  • What Is Biomarin Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 3.07%
  • What Is BMRN Return On Equity?
    ROE is a measure of profitability and is 4.22%

Biomarin Pharmaceutical Earnings Date & Stock Price

Biomarin Pharmaceutical Competitors

Biomarin Pharmaceutical Dividend Yield

Data Unavailable

Biomarin Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 70.37% 18.33%
Revenue: 8.79% -0.46%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 109.96
Upside from Last Price: 36.15%

Major Shareholders

  • How many BMRN shares are owned by institutional investors?
    303.2M BMRN shares are owned by institutional investors
  • How many BMRN shares are owned by insiders?
    2.5M BMRN shares are owned by insiders